PAX5 and precursor B-cell acute lymphoblastic leukemia: Loss of function mutations of IKZF1 and PAX5 are less prevalent, affecting fewer than 1% of paediatric B-ALL patients, but becoming more common in adolescent and young adult (AYA) and adult cohorts with PAX5 p.P80R detected in 3–4% of patients [5].